USANA Health Sciences, Inc.
USNANYSEConsumer Defensive● Active
$18.71
+$0.68(+3.75%)
Market Cap$345350621
P/E Ratio—
52W High$38.32
52W Low$16.6
USANA Health Sciences, Inc. (USNA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · USNA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-01 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.93B | $0.85B | $0.92B | $1.00B | $1.19B |
| Cost of Revenue | $0.20B | $0.18B | $0.19B | $0.21B | $0.23B |
| Gross Profit | $0.72B | $0.68B | $0.73B | $0.79B | $0.96B |
| Gross Margin %(computed) | 78.29% | 79.43% | 79.44% | 79.24% | 80.54% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.01B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.34B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.67B | $0.61B | $0.64B | $0.68B | $0.79B |
| Operating Income | $0.05B | $0.07B | $0.09B | $0.11B | $0.17B |
| Operating Margin %(computed) | 5.50% | 7.76% | 10.11% | 10.78% | 14.34% |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.04B | $0.08B | $0.10B | $0.11B | $0.17B |
| Income Tax Expense | $0.03B | $0.03B | $0.04B | $0.04B | $0.05B |
| Net Income | $0.01B | $0.04B | $0.06B | $0.07B | $0.12B |
| Net Margin %(computed) | 1.16% | 4.92% | 6.93% | 6.94% | 9.82% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.58 | $2.20 | $3.33 | $3.60 | $5.78 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | $0.08B | $0.10B | $0.12B | $0.13B | $0.19B |
| EBITDA Margin %(computed) | 8.87% | 11.57% | 13.37% | 13.04% | 16.26% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more USANA Health Sciences, Inc. data
About USANA Health Sciences, Inc. (USNA) Income Statement
USANA Health Sciences, Inc. (USNA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, USNA reported revenue of $0.93B, gross profit of $0.72B (gross margin 78.29%), and net income of $0.01B — a net profit margin of 1.16%.
Frequently asked questions
USNA · 4 questionsUSANA Health Sciences, Inc. (USNA) reported revenue of $0.93B for 2026, up 8.3% year-over-year.
USNA revenueUSNA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08